|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) | ||
| A61K 47/00 | (2006.01) |
| (11) | Number of the document | 2827885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13709231.8 |
| Date of filing the European patent application | 2013-03-15 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-15 |
| (46) | Date of publication of the claims translation | 2018-10-10 |
| (86) | Number | PCT/EP2013/055362 |
| Date | 2013-03-15 |
| (87) | Number | WO 2013/139694 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| 12160743 | 2012-03-22 | EP | |
| 201361748840 P | 2013-01-04 | US | |
| 13153459 | 2013-01-31 | EP |
| (72) |
VILHELMSEN, Thomas, DK
ELIASEN, Helle, DK
HANSEN, Tue, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | GLP-1 peptidų kompozicijos ir jų gavimas |
| COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-09-13 |